Autopsy report · NCT00504088

Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia

“Company decision to halt study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months after it had already started.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

FoxHollow Technologies

Sponsor type

Industry

Conditions

Peripheral Vascular Diseases

Interventions

Bypass; Silverhawk Plaque Excision

Sites

31

Countries

United States

Trials that died the same way

• A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease
  “Business decision to stop the study.” (83% match in meaning)
• Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma
  “Company decision not to start the study” (80% match in meaning)
• How Can a Driving Virtual Reality Tool Improve Quality of Life and Social Autonomy in Patients With Schizophrenia
  “Decision to stop the study” (80% match in meaning)
• Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)
  “Study stopped following management decision” (80% match in meaning)
• Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.
  “Study is withdrawn due to company decision.” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.